What would a daily progress note look like for a 68‑year‑old male on day 3 after an acute ischemic stroke with left‑sided hemiplegia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Daily Progress Note for Stroke Patient with Left Hemiplegia

A comprehensive daily note for a stroke patient with left hemiplegia must systematically document neurological status, complication surveillance, rehabilitation progress, and preventive interventions across multiple organ systems, following the American Heart Association's structured assessment framework. 11

Subjective Assessment

  • Patient-reported symptoms: Document any new weakness, numbness, speech difficulty, visual changes, headache, chest pain, shortness of breath, or pain (specify location and severity 0–10 scale). 11
  • Functional complaints: Ask specifically about difficulty swallowing, choking episodes, coughing with meals, ability to call for help, dizziness with position changes, and bowel/bladder control. 11
  • Mood and cognition: Screen for depressive symptoms (loss of interest, hopelessness, withdrawal from therapy), anxiety about recovery, and orientation to person/place/time. 12
  • Sleep quality: Document hours slept, nighttime awakenings, and daytime fatigue, as poststroke fatigue affects at least 50% of survivors. 2

Objective Findings

Vital Signs & Monitoring Parameters

  • Blood pressure: Record bilateral arm measurements; target <180/105 mmHg in first 24 hours post-thrombolysis or <220/120 mmHg if no reperfusion therapy given. 345
  • Temperature: Document every 4 hours; fever >38°C occurs in 13–64% of acute stroke patients and requires immediate workup for infection versus central fever. 116
  • Heart rate and rhythm: Note any new arrhythmia, as atrial fibrillation increases stroke risk fivefold and cardiac complications account for 2–6% of early mortality. 1
  • Respiratory rate and oxygen saturation: Auscultate lung fields bilaterally; chest infection occurs in 22–90% of critical stroke patients, peaking at 1–2 weeks. 67

Neurological Examination (NIHSS Documentation)

  • Level of consciousness: Score 0–3 for alertness, orientation (month, age), and command-following ("open/close eyes," "grip/release hand"). 3
  • Gaze and visual fields: Test horizontal eye movements (0–2) and confrontation visual fields in all four quadrants (0–3). 3
  • Facial symmetry: Ask patient to show teeth and raise eyebrows; score 0–3 for asymmetry. 3
  • Motor function—left arm: Hold arm outstretched at 90° (sitting) or 45° (supine) for 10 seconds; score 0 (no drift) to 4 (no movement). 38
  • Motor function—left leg: Raise leg to 30° for 5 seconds; score 0–4. 3
  • Sensory testing: Pinprick or light touch on face, arms, legs bilaterally; score 0 (normal), 1 (partial loss), or 2 (dense loss). 3
  • Language and speech: Assess naming, repetition, comprehension, and articulation; score aphasia 0–3 and dysarthria 0–2. 3
  • Neglect/extinction: Test with bilateral simultaneous tactile and visual stimulation; score 0–2. 3
  • Total NIHSS score: Sum all components (range 0–42); scores <5 indicate minor stroke, >20 severe stroke. 38
  • Comparison to prior: Document any increase ≥2 points, which signals neurological deterioration requiring immediate imaging and physician notification. 9

Complication Surveillance

Neurological Deterioration (occurs in 26–33% of patients)

  • Signs of progression: New or worsening weakness, decreased level of consciousness, new speech difficulty, or gaze deviation. 96
  • Hemorrhagic transformation risk factors: Document if patient received thrombolysis, has uncontrolled hypertension (SBP >180 mmHg), or shows early hypodensity on initial CT. 9
  • Cerebral edema indicators: Assess for headache, vomiting, declining consciousness, or pupillary changes, especially in large middle cerebral artery infarcts. 1

Respiratory Complications (chest infection in 22–90%)

  • Lung auscultation: Document presence of crackles, rhonchi, or decreased breath sounds in dependent lung zones. 67
  • Cough effectiveness: Note weak or absent cough, which increases aspiration risk. 1
  • Incentive spirometry: Record volume achieved and frequency of use (target every 2 hours while awake). 10

Dysphagia and Aspiration Risk (affects up to 78%)

  • Swallow screen status: Document pass/fail of bedside screen; oral intake must remain NPO until formal swallow assessment is completed, as aspiration pneumonia increases mortality sevenfold. 32
  • Signs of aspiration: Wet voice quality, coughing during meals, or temperature spike within 2 hours of eating. 12

Urinary Tract Infection (occurs in 24–30%)

  • Catheter status: Document if indwelling catheter present; remove within 48 hours to reduce UTI risk per CDC guidelines. 1210
  • Voiding pattern: Record frequency, volume, and post-void residual if measured; initiate intermittent catheterization if residual >100 mL on three consecutive checks. 1
  • Urine characteristics: Note color, clarity, and odor; cloudy or foul-smelling urine warrants urinalysis. 1

Constipation (incidence 45%)

  • Last bowel movement: Document date and stool consistency using Bristol scale. 1
  • Bowel sounds: Auscultate all four quadrants; absent sounds suggest ileus. 1
  • Interventions: Record stool softener administration (prophylactic per AHA guideline) and dietary fiber intake. 1

Venous Thromboembolism (DVT risk 75% without prophylaxis)

  • Lower extremity assessment: Measure bilateral calf circumference; unilateral swelling >2 cm, warmth, erythema, or calf tenderness requires Duplex ultrasound. 11
  • Intermittent pneumatic compression: Document device application and hours worn (target continuous use except during ambulation). 110
  • Pharmacologic prophylaxis: Record enoxaparin 40 mg SC or unfractionated heparin 5000 units SC administration after hemorrhagic transformation excluded at 24 hours. 110

Pressure Injury Risk (incidence 21%)

  • Braden scale score: Assess sensory perception, moisture, activity, mobility, nutrition, and friction/shear on admission and daily; score ≤18 indicates high risk. 11
  • Skin inspection: Examine sacrum, heels, greater trochanter, lateral malleolus, and left shoulder for non-blanchable erythema or skin breakdown. 110
  • Repositioning schedule: Document turns every 2 hours with time stamps; use pillows to offload heels. 1110

Hemiplegic Shoulder Care

  • Positioning: Record 30 minutes of maximum external rotation positioning completed (prevents subluxation per American Physical Therapy Association). 113
  • Sling use: Document if sling applied; use only during ambulation, not prolonged immobilization. 13
  • Pain assessment: Rate left shoulder pain 0–10; increased pain suggests subluxation or rotator cuff injury. 11
  • Passive range of motion: Document completion of gentle shoulder flexion, abduction, and external rotation; overhead pulley exercises are contraindicated (Class III) as they increase subluxation risk. 3

Fall Risk (25% fall during hospitalization)

  • Fall risk score: Use validated tool (Morse or Hendrich II); male sex, NIHSS ≥8, prior falls, and anxiety increase risk. 11
  • Environmental safety: Verify call bell within reach, bed in lowest position, non-skid footwear worn, and clutter removed. 12
  • Transfer ability: Document level of assistance required (independent, supervision, minimal/moderate/maximal assist, or dependent). 12

Nutritional Status (50% malnourished by 2–3 weeks)

  • Oral intake: Record percentage of each meal consumed and total fluid intake in mL. 1210
  • Weight: Weigh twice weekly; unintended loss >2 kg warrants dietitian consult. 10
  • Feeding route: Document oral, nasogastric, or percutaneous endoscopic gastrostomy; enteral nutrition should begin within 7 days if dysphagia persists. 1

Psychological Complications

  • Depression screening: Use PHQ-9 within first week; depression affects up to 33% and significantly impairs rehabilitation participation. 132
  • Delirium assessment: Apply 4AT or CAM-ICU daily; 25% develop delirium in acute period, with higher risk in older patients and right hemispheric strokes. 11
  • Emotional lability: Note inappropriate crying or laughing (pseudobulbar affect occurs in 10–48%). 11

Assessment & Clinical Reasoning

  • Stroke stability: State whether patient is neurologically stable (NIHSS unchanged), improving (NIHSS decreased), or deteriorating (NIHSS increased ≥2 points). 9
  • Complication summary: List active complications (e.g., "Day 3 post-stroke with dysphagia, urinary retention requiring intermittent catheterization, and Braden score 16 indicating pressure-injury risk"). 11
  • Rehabilitation potential: Note participation level in physical therapy, occupational therapy, and speech-language pathology (e.g., "Tolerated 20 minutes of bedside PT with moderate assistance for sit-to-stand transfers"). 13
  • Discharge trajectory: Document whether patient is progressing toward inpatient rehabilitation facility (requires ≥3 hours therapy tolerance), skilled nursing facility (<3 hours tolerance), or home with services (requires safe transfers and caregiver training). 2

Plan

Neurological Management

  • Continue neuro checks every 4 hours on stroke unit (or every 15 minutes × 2 hours, then every 30 minutes × 6 hours, then hourly × 16 hours if post-thrombolysis). 3
  • Notify physician immediately for NIHSS increase ≥2 points, new headache, vomiting, or decreased consciousness. 19
  • Maintain blood pressure <140/90 mmHg after acute phase (typically after 24 hours) using antihypertensive regimen. 34

Secondary Prevention

  • Administer aspirin 160–300 mg daily (started 24 hours post-thrombolysis or immediately if no reperfusion given). 35
  • Give high-intensity statin (atorvastatin 80 mg or rosuvastatin 20 mg) regardless of baseline LDL. 3
  • Monitor for atrial fibrillation on telemetry; anticoagulation timing 4–14 days post-stroke depending on infarct size. 3

Mobility & Rehabilitation

  • Physical therapy twice daily for progressive mobilization: bed mobility → sitting balance → standing → ambulation with assistive device. 1310
  • Occupational therapy for ADL training, adaptive equipment assessment, and left upper extremity passive range of motion. 13
  • Speech-language pathology for videofluoroscopic swallow study if bedside screen failed; continue NPO until cleared. 32

Complication Prevention

  • Reposition every 2 hours with documentation; apply pressure-redistributing mattress if Braden ≤18. 1110
  • Maintain intermittent pneumatic compression devices except during ambulation; continue enoxaparin 40 mg SC daily. 110
  • Remove Foley catheter by day 3; implement scheduled toileting every 2 hours during day and every 4 hours overnight. 1210
  • Administer prophylactic stool softener (docusate 100 mg twice daily); monitor for bowel movement every 3 days. 1
  • Position left shoulder in maximum external rotation for 30 minutes daily; perform gentle passive range of motion three times daily. 113

Nutritional Support

  • Maintain NPO until swallow study completed; if prolonged NPO (>7 days), place nasogastric tube for enteral nutrition. 12
  • Offer protein-rich oral supplements between meals once diet advanced; target 1500–2000 mL fluid intake daily. 10

Psychosocial Interventions

  • Complete PHQ-9 depression screen; refer to psychiatry or psychology if score ≥10. 12
  • Encourage family presence for orientation and emotional support; provide education on stroke recovery trajectory. 1
  • Schedule rest periods between therapy sessions to manage poststroke fatigue. 2

Discharge Planning

  • Coordinate occupational therapy home safety evaluation if home discharge anticipated. 2
  • Initiate caregiver training for transfers, positioning, shoulder care, and complication recognition. 2
  • Arrange outpatient rehabilitation referrals and neurology follow-up within 7–14 days of discharge. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Discharge Planning for Stroke Patients with Immobile Upper Extremity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evidence‑Based Acute and Post‑Acute Management of Ischemic Stroke with Hemiplegia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Clinical Case of the Month: A 49 Year-Old Man Who Presents with Left Sided Weakness: An Update on Ischemic Stroke.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 2016

Guideline

Nursing Care Plan for Impaired Mobility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the clinical presentations distinguishing a cerebral hemorrhage (intracerebral bleed) from an ischemic infarct (stroke)?
What are the key recommendations of the 2026 American Heart Association/American Stroke Association guideline for the early management of acute ischemic stroke?
Are there articles that describe the clinical presentation of intracerebral hemorrhage versus ischemic infarction?
Can hypertension cause cerebral infarction?
What are the key updates in the 2026 acute ischemic stroke guideline?
Can you provide an example of a physical therapy daily note for a 68‑year‑old male with a left intertrochanteric femoral fracture who is five days post‑operative open reduction internal fixation, has hypertension and type‑2 diabetes mellitus, is taking lisinopril 10 mg daily, metformin 500 mg twice daily, and acetaminophen 650 mg every six hours as needed for pain, reports pain 4/10 at rest and 6/10 during activity, and is weight‑bearing as tolerated with a walker?
What pharmacologic agents can be used to enhance gastrointestinal motility in an adult postoperative patient with delayed gut motility after abdominal or gastrointestinal surgery?
What are the clinical indications for guanfacine?
The patient’s INR is 1.75 while on warfarin 2.5 mg daily; should the warfarin dose be increased?
In a typical reproductive‑age female patient, does combined oral contraceptive therapy increase low‑density lipoprotein (LDL) cholesterol?
How much should I increase the warfarin dose for a patient taking 2.5 mg daily with an INR of 1.75?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.